Opioid Use Disorder Treatment Market Growth, Analysis, Trends and Forecast 2023 to 2033

According to market predictions, the global Opioid Use Disorder Treatment market revenue will be worth US$ 3.07 billion in 2023 and will grow at a CAGR of 10.5% during the forecast period, reaching US$ 8.4 billion by 2033. The providers and manufacturers of drug abuse therapy are primarily concerned with raising public and drug store owner knowledge of the dangers of drug misuse and the importance of obtaining treatment. This technique contributes to the expansion of the Opioid Use Disorder Treatment business by increasing their customer base. Various media, such as television commercials, newspapers, and information brochures, are being used effectively to raise awareness and combat the opioid epidemic.

Collaborations between diverse organisations are also fueling the industry's growth. For example, GlaxoSmithKline collaborated with 2morrow Inc., the producer of the SmartQuit app, in March 2016 to deliver patches to smokers who adhered to the app's plan. Similarly, in August 2013, the business agreed to collaborate with Amneal Pharmaceuticals LLC to offer its generic version of Suboxon, Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets (CIII), to addiction treatment centres. In the long run, these collaborations are projected to assist the opioid use disorder therapy market.

Competitive Landscape

The market for Opioid Use Disorder Treatment is competitive, with numerous significant companies. Major players are developing innovative opioid delivery methods to treat opioid use disorder. This is projected to push the market for Opioid Use Disorder Treatment. The major players in the market are: Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., BioDelivery Sciences International, Inc.

Browse More Details@ https://www.futuremarketinsights.com/reports/opioid-use-disorder-treatment-market

Key Segments Profiled in the Opioid Use Disorder Treatment Market Survey

By Drug Type:

  • Romiplostim
  • Omidubicel
  • Nalmefene
  • Buprenorfine
  • Methadone
  • Naltrexone

By Route of Administration:

  • Oral
  • Parenteral

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more